(Q34492848)

2 August 2017

1 reference

title

Endothelin antagonists and heart failure (English)

1 reference

2 August 2017

1 reference

5

Frank Ruschitzka

1 reference

2 August 2017

4

Thomas F Lüscher

1 reference

2 August 2017

David Hürlimann

1

1 reference

2 August 2017

Frank Enseleit

series ordinal

2

1 reference

2 August 2017

Georg Noll

series ordinal

3

1 reference

2 August 2017

publication date

1 February 2002

1 reference

Current Hypertension Reports

2 August 2017

published in

1 reference

2 August 2017

volume

4

1 reference

2 August 2017

issue

1

1 reference

2 August 2017

page(s)

85-92

1 reference

https://scigraph.springernature.com/pub.10.1007/s11906-002-0058-6

2 August 2017

exact match

0 references

cites work

Survival after the onset of congestive heart failure in Framingham Heart Study subjects

1 reference

https://api.crossref.org/works/10.1007%2FS11906-002-0058-6

Endothelium-derived contracting factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-002-0058-6

Endothelin-1-induced vasoconstriction in humans. Reversal by calcium channel blockade but not by nitrovasodilators or endothelium-derived relaxing factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-002-0058-6

Endothelin-A receptor antagonist-mediated vasodilatation is attenuated by inhibition of nitric oxide synthesis and by endothelin-B receptor blockade.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-002-0058-6

Endothelin 1 type a receptor antagonism prevents vascular dysfunction and hypertension induced by 11beta-hydroxysteroid dehydrogenase inhibition: role of nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-002-0058-6

Expression of endothelin-1, endothelin-converting enzyme, and endothelin receptors in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-002-0058-6

Hemodynamic effects of tezosentan, an intravenous dual endothelin receptor antagonist, in patients with class III to IV congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-002-0058-6

Short-term oral endothelin-receptor antagonist therapy in conventionally treated patients with symptomatic severe chronic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-002-0058-6

Endothelin ETA and ETB receptors mediate vascular smooth muscle contraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-002-0058-6

Both ETA and ETB receptors mediate contraction to endothelin-1 in human blood vessels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-002-0058-6

The human preproendothelin-1 gene. Complete nucleotide sequence and regulation of expression.

21 January 2018

1 reference

12 December 2020

Epidemiology of heart failure in the United States

1 reference

12 December 2020

Value of cardiopulmonary exercise testing and big endothelin plasma levels to predict short-term prognosis of patients with chronic heart failure

1 reference

12 December 2020

Endothelin is a potent mitogen for rat vascular smooth muscle cells

1 reference

12 December 2020

Endothelin-A receptor mediates cardiac inhibition by regulating calcium and potassium currents

1 reference

12 December 2020

Effects of chronic ETA-receptor blockade in angiotensin II-induced hypertension

1 reference

12 December 2020

Evidence for endothelin-1-mediated vasoconstriction in severe chronic heart failure.

1 reference

12 December 2020

Endothelin stimulates phospholipase C in cultured vascular smooth muscle cells

1 reference

12 December 2020

Endothelin-1 induces hypertrophy with enhanced expression of muscle-specific genes in cultured neonatal rat cardiomyocytes

1 reference

12 December 2020

Short-term haemodynamic effects of BQ-123, a selective endothelin ET(A)-receptor antagonist, in chronic heart failure

1 reference

12 December 2020

Role of endothelin receptor subtypes in the in vivo regulation of renal function

1 reference

12 December 2020

Angiotensin II increases tissue endothelin and induces vascular hypertrophy: reversal by ET(A)-receptor antagonist

1 reference

12 December 2020

Exogenous effects and endogenous production of endothelin in cardiac myocytes: potential significance in heart failure

1 reference

12 December 2020

Human urotensin-II, the most potent mammalian vasoconstrictor identified to date, as a therapeutic target for the management of cardiovascular disease

1 reference

12 December 2020

Contrasting inotropic effects of endogenous endothelin in the normal and failing human heart: studies with an intracoronary ET(A) receptor antagonist

1 reference

12 December 2020

Plasma endothelin correlates with the extent of pulmonary hypertension in patients with chronic congestive heart failure

1 reference

12 December 2020

Acute hemodynamic and neurohumoral effects of selective ET(A) receptor blockade in patients with congestive heart failure. ET 003 Investigators

1 reference

12 December 2020

Hemodynamic and coronary effects of the endothelin antagonist bosentan in patients with coronary artery disease

1 reference

12 December 2020

Angiotensin II increases vascular and renal endothelin-1 and functional endothelin converting enzyme activity in vivo: role of ETA receptors for endothelin regulation

1 reference

12 December 2020

ET(A) receptor blockade prevents increased tissue endothelin-1, vascular hypertrophy, and endothelial dysfunction in salt-sensitive hypertension

1 reference

12 December 2020

Clearance of circulating endothelin-1 by ETB receptors in rats

1 reference

12 December 2020

Reduced pulmonary clearance of endothelin-1 contributes to the increase of circulating levels in heart failure secondary to myocardial infarction

1 reference

12 December 2020

Pulmonary hypertension caused by congestive heart failure is ameliorated by long-term application of an endothelin receptor antagonist. Increased expression of endothelin-1 messenger ribonucleic acid and endothelin-1-like immunoreactivity in the lun

1 reference

12 December 2020

Prognostic value of plasma endothelin-1 in patients with chronic heart failure

1 reference

12 December 2020

Pulmonary clearance of circulating endothelin-1 in dogs in vivo: exclusive role of ETB receptors

1 reference

12 December 2020

Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor

1 reference

12 December 2020

Endothelin mediates the altered renal hemodynamics associated with experimental congestive heart failure

1 reference

12 December 2020

Systemic Blockade of the Endothelin-B Receptor Increases Peripheral Vascular Resistance in Healthy Men

1 reference

12 December 2020

Atrial natriuretic peptide inhibits the production and secretion of endothelin from cultured endothelial cells. Mediation through the C receptor.

1 reference

12 December 2020

ETA receptors predominate in the human vasculature and mediate constriction

1 reference

12 December 2020

Endothelin enhances the contractile responsiveness of adult rat ventricular myocytes to calcium by a pertussis toxin-sensitive pathway

1 reference

12 December 2020

Role of endothelin in the maintenance of blood pressure in conscious rats with chronic heart failure. Acute effects of the endothelin receptor antagonist Ro 47-0203 (bosentan)

1 reference

12 December 2020

Vasoconstriction to endogenous endothelin-1 is increased in the peripheral circulation of patients with essential hypertension

1 reference

12 December 2020

Regional vasodilation is a prominent feature of the haemodynamic response to endothelin in anaesthetized, spontaneously hypertensive rats.

1 reference

12 December 2020

Role of blood pressure in the development of congestive heart failure. The Framingham study

1 reference

12 December 2020

A novel potent vasoconstrictor peptide produced by vascular endothelial cells

1 reference

12 December 2020

A pilot safety trial of prolonged (48 h) infusion of the dual endothelin-receptor antagonist tezosentan in patients with advanced heart failure

1 reference

12 December 2020

ECE-1: a membrane-bound metalloprotease that catalyzes the proteolytic activation of big endothelin-1

1 reference

12 December 2020

The effect of an endothelin-receptor antagonist, bosentan, on blood pressure in patients with essential hypertension. Bosentan Hypertension Investigators

1 reference

12 December 2020

Release of endothelin from the porcine aorta. Inhibition by endothelium-derived nitric oxide

1 reference

12 December 2020

Comparison of the effects of selective endothelin ETA and ETB receptor antagonists in congestive heart failure

1 reference

12 December 2020

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

1 reference

12 December 2020

Effect of endothelin-1 on actomyosin ATPase activity. Implications for the efficiency of contraction

1 reference

12 December 2020

Elevated endothelin-1 in heart failure and loss of normal response to postural change

1 reference

12 December 2020

1 reference

12 December 2020

Endothelin receptors in the failing and nonfailing human heart

1 reference

12 December 2020

ET(A) receptor antagonist prevents blood pressure elevation and vascular remodeling in aldosterone-infused rats

1 reference

12 December 2020

Endothelin-converting enzyme-2 is a membrane-bound, phosphoramidon-sensitive metalloprotease with acidic pH optimum

1 reference

12 December 2020

Cloning and functional expression of a vascular smooth muscle endothelin 1 receptor

1 reference

12 December 2020

Cloning and expression of a cDNA encoding an endothelin receptor

1 reference

12 December 2020

Inhibition of the cardiac protein kinase A-dependent chloride conductance by endothelin-1

1 reference

12 December 2020

Endothelin B receptors are functionally important in mediating vasoconstriction in the systemic circulation in patients with left ventricular systolic dysfunction.

1 reference

12 December 2020

Human pulmonary circulation is an important site for both clearance and production of endothelin-1

1 reference

12 December 2020

Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor

1 reference

12 December 2020

Expression of endothelin-1 and endothelin-converting enzyme-1 mRNAs and proteins in failing human hearts

1 reference

12 December 2020

ETB-mediated regulation of extracellular levels of endothelin-1 in cultured human endothelial cells

1 reference

12 December 2020

The progression from hypertension to congestive heart failure

1 reference

12 December 2020

Role of endothelin receptor subtypes in the systemic and renal responses to endothelin-1 in humans

1 reference

12 December 2020

Acute endothelin A receptor blockade causes selective pulmonary vasodilation in patients with chronic heart failure

1 reference

12 December 2020

1 reference

12 December 2020

Increased plasma endothelin level in patients with essential hypertension

1 reference

12 December 2020

Chronic ETA receptor blockade attenuates cardiac hypertrophy independently of blood pressure effects in renovascular hypertensive rats

1 reference

12 December 2020

Endothelin in human congestive heart failure

1 reference

12 December 2020

Plasma big endothelin-1 concentrations in congestive heart failure patients with or without systemic hypertension

1 reference

12 December 2020

10.1007/S11906-002-0058-6

Identifiers

DOI

1 reference

Dimensions Publication ID

2 August 2017

1050009993

0 references

1 reference